Diffuse Large B-cell Lymphoma, NOS, Centroblastic
Francisco Vega, MD, PhD
Key Facts
Terminology
Diffuse proliferation of large neoplastic B cells composed predominantly of centroblasts
Typical: Medium to large cells (10-14 µm) with fine chromatin, 2-3 small nucleoli often apposed to nuclear membrane, and scant basophilic cytoplasm
Clinical Issues
Most frequent morphologic variant of DLBCL
Microscopic Pathology
Diffuse growth pattern and predominantly composed of centroblasts
Sclerosis is frequent in extranodal sites
Usually express pan-B markers: CD20, CD22, CD79a, PAX5
Germinal center markers, CD10 and Bcl-6, expressed in variable proportion of cases
Ancillary Tests
t(14;18) is detected in almost 30% of cases; translocations involving 3q27 are also common
2 major molecular groups of DLBCL
GC type
ABC type
Patients with DLBCL of GC type have better prognosis than those with ABC type
Top Differential Diagnoses
DLBCL, immunoblastic variant
DLBCL, anaplastic variant
Plasmablastic lymphoma
Follicular lymphoma (grade 3B)
TERMINOLOGY
Abbreviations
Diffuse large B-cell lymphoma (DLBCL), centroblastic
Synonyms
Centroblastic lymphoma
Definitions
Diffuse proliferation of large neoplastic B cells composed predominantly of centroblasts
Centroblasts
Typical: Medium to large cells (10-14 µm) with fine chromatin, 2-3 small nucleoli often closely apposed to nuclear membrane, and scant basophilic cytoplasm
Multilobated: Medium to large cells with lobated nuclei (> 3 lobes)
CLINICAL ISSUES
Epidemiology
Incidence
Predominantly disease of adults and elderly but also occurs in children and young adults
Most frequent morphologic variant of DLBCL
Presentation
Enlarging mass in nodal or extranodal sites
Gastrointestinal tract is frequent extranodal site
Stage IV in at least 1/3 of cases
Bone marrow involvement occurs less frequently than in patients with low-grade B-cell lymphomas
Certain morphologic variants more prevalent at particular extranodal sites
Cells with multilobated nuclei in cases involving bone
Treatment
R-CHOP regimen (rituximab + cyclophosphamide, doxorubicin, vincristine, prednisone)Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree